MedPath

Comparison the Effect of Quetiapine and Haloperidol on the Treatment of ?delirium in IC

Phase 2
Recruiting
Conditions
delirium.
Delirium due to known physiological condition
Registration Number
IRCT20180911040998N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Delirium detection
more than 18 years

Exclusion Criteria

Dissatisfaction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: Every day to end of intervention. Method of measurement: Richmond agitation and sedation scale.;Illness severity. Timepoint: 1, 3, 7 and 10 day after start of intervention. Method of measurement: APACHE II.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath